GlucoTrack Inc. GCTK shares surged 70.25% to $0.49 after the bell on Wednesday, following the announcement that its ...
GlucoTrack Inc. GCTK shares climbed 15.98% to $0.58 in after-hours trading on Thursday. The late trading session surge reverses a 5.48% intraday decline, which closed the stock of the medical device ...
By Karen Roman Glucotrack, Inc. (Nasdaq: GCTK) said the US Patent and Trademark Office issued a Notice of Allowance for a patent application which expands the intellectual property protecting the ...
Rutherford, NJ, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and ...
(Nasdaq: GCTK) today announced the completion of its strategic business combination with Lōkahi Therapeutics, establishing a publicly listed, capital-efficient platform for the identification, ...
RUTHERFORD, N.J. & LA JOLLA, Calif.-- (BUSINESS WIRE)--Jul 29, 2026-- ...
Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization ...
Glucotrack repurchased over 90% of its Series A Warrants, strengthening its capital structure and demonstrating confidence in product development. Glucotrack, Inc. has announced the successful ...
Rutherford, NJ & Brooklyn Park, MN, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel ...
Peer-Reviewed Studiespublished in The Journal of Diabetes Research and in the Institute of Electrical and Electronics Engineers (IEEE) Sensors Journal support advancement of Company’s implantable CBGM ...
Glucotrack, Inc. GCTK reports it has achieved a significant milestone in its mission to transform diabetes management through three distinct advances: direct blood glucose measurement, hassle-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results